Genocea Biosciences financials at a glance
| Year | Year | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2012 | 2013 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
$0.31M | $0.67M | $0.24M | $0.00M | $0.00M | $0.00M | $1.36M | $1.64M | $0.00M | $0.00M | $1.98M | $0.73M | $0.00M |
| GM % | Gross Margin % |
|
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 100.00% | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| OM | Operating Margin |
|
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | Earnings Per Share |
|
$-555.04 | $-18.16 | $-13.92 | $-14.00 | $-4.16 | $-1.89 | $-0.98 | $-0.48 | $0.00 | ||||
| Div. | Dividends |
|
$0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| PR % | Payout Ratio % |
|
-0.00% | -0.00% | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sha. | Shares |
|
2.23m | 3.51m | 3.55m | 3.54m | 10.83m | 26.15m | 51.64m | 57.45m | 58.73m | 0m | 0m | 0m | 0m |
| OCF | Operating Cash Flow |
|
$-27.60M | $-38.36M | $-41.84M | $-47.60M | $-41.24M | $-37.73M | $-41.65M | $-45.37M | $0.00M | $0.00M | $-12.68M | $-19.87M | $0.00M |
| FCF | Free Cash Flow |
|
$-29.12M | $-41.14M | $-44.37M | $-48.78M | $-41.48M | $-38.87M | $-44.24M | $-48.66M | $0.00M | $0.00M | $-13.14M | $-20.26M | $0.00M |
| FCFS | Free Cash Flow Per Share |
|
$-14.92 | $-13.46 | $-12.54 | $-13.64 | $-4.02 | $-1.88 | $-1.00 | $-0.71 | $0.00 | $0.00 | $-356.37 | $-545.78 | $0.00 |